Synthesis and mesomorphic properties of some platinum(II) and oxovanadium(IV) complexes

The synthesis and mesomorphic properties of a homologous series of N-(2-hydroxy-4-n-alkoxybenzylidene)-4'-n-decylphenylanilines and their platinum(II) and oxovanadium(IV) complexes are reported. All the ligands and their metal chelates exhibit enantiotropic mesophases, predominantly smectic A and smectic C phases. The transition temperatures and enthalpies have been determined for most of the compounds. The platinum(II) complexes have higher melting points and mesophase thermal stabilities. However, the oxovanadium(IV) complexes have a wider thermal range for the mesophase. Both platinum(II) and oxovanadium(IV) complexes containing only a chain on the biphenyl moiety exhibit a nematic phase.     

Synthesis and characterizations of N,N-bis(diphenylphosphino)ethylaniline derivatives and X-ray crystal structure of palladium (II), platinum (II) complexes

N,N-Bis(diphenylphosphino)ethylaniline compounds, [Ph₂P]₂N-C₆H₄-C₂H₅, with ethyl groups at the ortho- and para-positions have been synthesized. Oxidation of the aminophosphines with hydrogen peroxide, elemental sulfur and selenium gave the corresponding oxides, sulfides and selenides [Ph₂P(E)]₂N-C₆H₄-C₂H₅ (E = O, S, Se). Complexes [MCl₂{(Ph₂P)₂N-C₆H₄-(C₂H₅)}] (M = Pd, Pt) and [Cu{(Ph₂P)₂N-C₆H₄-C₂H₅}₂]PF₆ were obtained by the reaction of N,N-bis(diphenylphosphino)ethylaniline with [MCl₂(COD)] (M = Pd, Pt) and [Cu(MeCN)₄]PF₆. The new compounds were characterized by NMR, IR spectroscopy and microanalysis. In addition, representative solid-state structures of the palladium and platinum complexes were determined using single crystal X-ray diffraction analyses.     

Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes

The synthesis, characterization, and cytotoxicity of eight new platinum(IV) complexes having the general formula cis,cis,trans-[Pt(NH(3))(2)Cl(2)(O(2)CNHR)(2)] are reported, where R = tert-butyl (4), cyclopentyl (5), cyclohexyl (6), phenyl (7), p-tolyl (8), p-anisole (9), 4-fluorophenyl (10), or 1-naphthyl (11). These compounds were synthesized by reacting organic isocyanates with the platinum(IV) complex cis,cis,trans-[Pt(NH(3))(2)Cl(2)(OH)(2)]. The electrochemistry of the compounds was investigated by cyclic voltammetry. The aryl carbamate complexes 7-11 exhibit reduction peak potentials near -720 mV vs Ag/AgCl, whereas the alkyl carbamate complexes display reduction peak potentials between -820 and -850 mV vs Ag/AgCl. The cyclic voltammograms of cis,cis,trans-[Pt(NH(3))(2)Cl(2)(O(2)CCH(3))(2)] (1), cis,cis,trans-[Pt(NH(3))(2)Cl(2)(O(2)CCF(3))(2)] (2), and cis-[Pt(NH(3))(2)Cl(4)] (3) were measured for comparison. Density functional theory studies were undertaken to investigate the electronic structures of 1-11 and to determine their adiabatic electron affinities. A linear correlation (R(2) = 0.887) between computed adiabatic electron affinities and measured reduction peak potentials was discovered. The biological activity of 4-11 and, for comparison, cisplatin was evaluated in human lung cancer A549 and normal MRC-5 cells by the MTT assay. The compounds exhibit comparable or slightly better activity than cisplatin against the A549 cells. In MRC-5 cells, all are equally or slightly less cytotoxic than cisplatin, except for 4 and 5, which are more toxic.     

Cyclometallated platinum(II) complexes: oxidation to, and C-H activation by, platinum(IV)

A series of cyclometallated phenylpyridine platinum(II) complexes have been synthesised with a systematic variation in both the phenylpyridine and the ancillary ligand. Oxidation of one of the cyclometallated species leads to a number of isomeric platinum(IV) complexes, all of which eventually isomerize to a single compound. The route to these new compounds has been demonstrated to involve an initial slow oxidation followed by a rapid C-H activation to give doubly cyclometallated complexes. The solid state structures of a number of both the platinum(II) and the platinum(IV) species have been solved; many of the structures exhibited extended interactions that result in complex three dimensional packing.     

Synthesis and characterization of luminescent bis-cyclometalated platinum(IV) complexes

Presented is the synthesis and characterization of a series of luminescent heteroleptic bis-cyclometalated platinum(IV) complexes. An oxidation-facilitated cyclometalation is employed to convert platinum(II) pendant species into bis-cyclometalated platinum(IV) dichlorides, which are transformed into the tris-chelated diimine complexes through ligand substitution. The structure-property relationship is probed by judiciously varying substituents on both the C(∧)N and the N(∧)N ligands resulting in a family of complexes exhibiting blue emission, long excited-state lifetimes, and highly efficient oxygen quenching. Excited-state properties are corroborated by static and time-dependent density-functional theory calculations of both the singlet and the triplet state.     

The thermal decomposition of platinum(II) and (IV) complexes

The decomposition characteristics of Pt(II) and Pt(IV) complexes in hydrogen, air and argon were investigated by thermal gravimetric and differential thermal analysis. Based on weight-loss measurements, the thermal stability in hydrogen increased in the order: hexachloroplatinic acid<platinum acetyl acetonate<platinum diamino dinitrite<tetrammine platinous hydroxide<tetrammine platinous chloride<platinum phthalocyanine; whereas in air, the order was: hexachloroplatinic acid<tetrammine platinous hydroxide<platinum acetyl acetonate<platinum diamino dinitrite<tetrammine platinous chloride. The platinum complexes were more stable in air than in hydrogen where decomposition was observed in all platinum samples at temperatures below 200°C.     

N-aminorhodamne complexes of palladium(II), palladium(IV) and platinum(II)

Summary TheN-aminorhodanine (L) complexes: PdLX, (X = Br or I), ML_1.5Cl₂ (M = Pd or Pt), PtL₂X₂ (X = Br, I or ClO₄), PdL₃(ClO₄)₂, PdL_1.5Cl₄ and PdL₃(ClO₄)₄ have been prepared and investigated. The ligand is bonded to the metal ion through the aminic nitrogen atom as monodentate or through this atom and the thiocarbonylic sulphur atom when it acts as chelating or bridging ligand. The carbonylic oxygen atom is never coordinated.     

Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes

Guanosine derivatives with a nucleophilic group at the 5' position (G-5') are oxidized by the Pt (IV) complex Pt( d, l)(1,2-(NH 2) 2C 6H 10)Cl 4 ([Pt (IV)(dach)Cl 4]). The overall redox reaction is autocatalytic, consisting of the Pt (II)-catalyzed Pt (IV) substitution and two-electron transfer between Pt (IV) and the bound G-5'. In this paper, we extend the study to improve understanding of the redox reaction, particularly the substitution step. The [Pt (II)(NH 3) 2(CBDCA-O,O')] (CBDCA = cyclobutane-1,1-dicarboxylate) complex effectively accelerates the reactions of [Pt (IV)(dach)Cl 4] with 5'-dGMP and with cGMP, indicating that the Pt (II) complex does not need to be a Pt (IV) analogue to accelerate the substitution. Liquid chromatography/mass spectroscopy (LC/MS) analysis showed that the [Pt (IV)(dach)Cl 4]/[Pt (II)(NH 3) 2(CBDCA-O,O')]/cGMP reaction mixture contained two Pt (IV)cGMP adducts, [Pt (IV)(NH 3) 2(cGMP)(Cl)(CBDCA-O,O')] and [Pt (IV)(dach)(cGMP)Cl 3]. The LC/MS studies also indicated that the trans, cis-[Pt (IV)(dach)( (37)Cl) 2( (35)Cl) 2]/[Pt (II)(en)( (35)Cl) 2]/9-EtG mixture contained two Pt (IV)-9-EtG adducts, [Pt (IV)(en)(9-EtG)( (37)Cl)( (35)Cl) 2] and [Pt (IV)(dach)(9-EtG)( (37)Cl)( (35)Cl) 2]. These Pt (IV)G products are predicted by the Basolo-Pearson (BP) Pt (II)-catalyzed Pt (IV)-substitution scheme. The substitution can be envisioned as an oxidative addition reaction of the planar Pt (II) complex where the entering ligand G and the chloro ligand from the axial position of the Pt (IV) complex are added to Pt (II) in the axial positions. From the point of view of reactant Pt (IV), an axial chloro ligand is thought to be substituted by the entering ligand G. The Pt (IV) complexes without halo axial ligands such as trans, cis-[Pt(en)(OH) 2Cl 2], trans, cis-[Pt(en)(OCOCF 3) 2Cl 2], and cis, trans, cis-[Pt(NH 3)(C 6H 11NH 2)(OCOCH 3) 2Cl 2] ([Pt (IV)(a,cha)(OCOCH 3) 2Cl 2], satraplatin) did not react with 5'-dGMP. The bromo complex, [Pt (IV)(en)Br 4], showed a significantly faster substitution rate than the chloro complexes, [Pt (IV)(en)Cl 4] and [Pt (IV)(dach)Cl 4]. The results indicate that the axial halo ligands are essential for substitution and the Pt (IV) complexes with larger axial halo ligands have faster rates. When the Pt (IV) complexes with different carrier ligands were compared, the substitution rates increased in the order [Pt (IV)(dach)Cl 4] < [Pt (IV)(en)Cl 4] < [Pt (IV)(NH 3) 2Cl 4], which is in reverse order to the carrier ligand size. These axial and carrier ligand effects on the substitution rates are consistent with the BP mechanism. Larger axial halo ligands can form a better bridging ligand, which facilitates the electron-transfer process from the Pt (II) to Pt (IV) center. Smaller carrier ligands exert less steric hindrance for the bridge formation.     

Synthesis,characterization and X-ray crystal structures of polyether and ethylene bridged bis(azolyl) platinum(II) complexes

The preparation of platinum(II) complexes of the types [PtCl₂{Y(CH₂CH₂O) _x CH₂CH₂Y}] (Y: imidazol-1-yl, im; pyrazol-1-yl, pz or benzimidazol-1-yl, bim) and [PtI₂{im(CH₂CH₂O) _x CH₂CH₂im}] with varying ligand backbone length (x between 0 and 3) is described. A new bis(pyrazol-1-yl) polyether compound, pz(CH₂CH₂O)₂CH₂CH₂pz, is reported. Spectroscopic characterization of the complexes is discussed. Two crystal structures of the general formula [PtCl₂{im(CH₂CH₂O) _x CH₂CH₂im}] (x is 1 or 3) are also reported.     

Palladium(II) and platinum(II),(IV) complexes of 2-aminopyrimidine derivatives

Palladium(II) and Platinum(II),(IV) complexes with 2-aminopyrimidine derivatives (L1)–(L3), prepared by reacting the corresponding metal halide with the ligand in the required stoichiometric ratio, were characterised by chemical analyses and physical measurements. The structures have been assigned on the basis of i.r. spectroscopy, electronic reflectance spectra and molar conductivities.     

Novel platinum(II) and (IV) complexes of naphthaldimine schiff bases

Naphthaldimines containing N₂O₂ donor centers react with platinum(II) and (IV) chlorides to give two types of complexes depending on the valence of the platinum ion. For [Pt(II)], the ligand is neutral, [(H₂L¹)PtCl₂]·3H₂O (1) and [(H₂L³)₂Pt₂Cl₄]·5H₂O (3), or monobasic [(HL²)₂Pt₂Cl₂]·2H₂O (2) and [(HL⁴)₂Pt]·2H₂O (4). These complexes are all diamagnetic having square-planar geometry. For [Pt(IV)], the ligand is dibasic, [(L¹)Pt₂Cl₄(OH)₂]·2H₂O (5), [(L²)Pt₃Cl₁₀]·3H₂O (6), [(L³)Pt₂Cl₄(OH)₂]·C₂H₅OH (7) and [(L⁴)Pt₂Cl₆]·H₂O (8). The Pt(IV) complexes are diamagnetic and exhibit octahedral configuration around the platinum ion. The complexes were characterized by elemental analysis, UV-Vis and IR spectra, electrical conductivity and thermal analyses (DTA and TGA). The molar conductances in DMF solutions indicate that the complexes are non-ionic. The complexes were tested for their catalytic activities towards cathodic reduction of oxygen.     

Synthesis,characterization, and antitumor activity of novel tumor-targeted platinum(IV) complexes

Four tumor-targeted platinum(IV) complexes with ammonia and cyclohexylamine as the carrier groups and biotin as the axial group were designed, synthesized, and characterized. In vitro evaluation of the antitumor activity of complexes C1–C4 against lung cancer cells (A549), liver cancer cells (SMMC-7721), breast cancer cells (MCF-7), and colon cancer cells (SW480) was carried out. Complex C3 had the best cellular activity. Compared with cisplatin, complex C3 showed good anticancer activity against A549 cell line,complex C3 (6.34±0.44) is 3 times more cytotoxic than cisplatin (19.40±0.71),and against MCF-7 cell line complex C3 (4.22±0.11) is 5.4 times more cytotoxic than cisplatin (22.96±0.58), and against SW480 cell line complex C3 (6.65±0.60) is 3.4 times more cytotoxic than cisplatin (23.15±0.22). (Table 1) Axial chloride increased the redox power of complex C3 to increase the intercellular accumulation and the introduction of mixed amine had the ability to overcome cisplatin resistance. Complex C3 works best on MCF-7, then SW480, A549, and SMMC-7721. Thus, complex C3 is targeted by the axial introduction of biotin.     

Synthesis and characterization of dinuclear pyrazolato bridged platinum(IV) complexes

Reactions of [PtMe₃(OCMe₂)₃](BF₄) and [(PtMe₃I)₄] with pyrazole (pzH) afforded mononuclear pyrazole platinum(IV) complexes [PtMe₃(pzH)₃](BF₄) (1) and [PtMe₃I(pzH)₂] (2), respectively. The formation of dinuclear pyrazolato bridged platinum(IV) complexes (PPN)[(PtMe₃)₂(μ-pz)₃] (3), (PPN)[(PtMe₃)₂(μ-I)(μ-pz)₂] · 1/2Et₂O (4) and [K(18C6)][(PtMe₃)₂(μ-I)(μ-pz)₂] (5) was achieved by the reaction of each 1 and 2 with [PtMe₃(OCMe₂)₃](BF₄) in the presence of KOAc followed by reaction with (PPN)Cl (PPN⁺ = bis(triphenylphosphine)iminium cation) and 18C6, respectively. The reaction of complex 4 with AgO₂CCF₃ followed by addition of RSR′ (R/R′ = Me/Me, Me/Ph) resulted in the formation of complexes [(PtMe₃)₂(μ-pz)₂(μ-RSR′)] (R/R′ = Me/Me, 6; Me/Ph, 7). All complexes were characterized unambiguously by microanalysis and NMR (¹H, ¹³C) spectroscopic investigations. Additionally, crystal structures of complexes 3 and 4 as well as DFT calculation are presented. Furthermore, in vitro studies on the anti-proliferative activity of complexes 2 and 5 were carried out.     

Platinum(II) and platinum(IV) complexes of 2-amino-4, 6-dimethylpyrimidine

Summary Platinum(II) and platinum(IV) complexes of 2-amino-4, 6-dimethylpyrimidine, ADMPY, have been prepared. Solids of formula Pt(ADMPYH⁺)Cl₃, Pt(ADMPY)₂Cl₄ and Pt(ADMPY)₂Cl₄·2HCl have been isolated and characterized by elemental analyses in conjuction with i.r. and n.m.r. spectra. A paramagnetic tan to reddishbrown complex has been reproducibly prepared from the direct reaction of K₂PtCl₄ and ADMPY at pH 6.     

Novel platinum pyridinehydroxamic acid complexes: Synthesis,characterisation, X-ray crystallographic study and nitric oxide related properties

Herein, we describe the synthesis and characterisation of a novel class of Pt^II and Pt^IV pyridinehydroxamic acid (pyhaH) complexes of general formula cis-[Pt^IICl₂(x-pyhaH)₂] and cis-[Pt^IVCl₄(x-pyhaH)₂], respectively (where x = 3 or 4) in which the pyridinehydroxamic acid is coordinated to the platinum ion via the pyridine nitrogen only leaving the hydroxamic acid free to potentially release cytotoxic nitric oxide (NO). The crystal structure of the Pt^IV derivative, cis-[PtCl₄(4-pyhaH)₂] · 2CH₃OH is reported. To establish the biological effect of the uncoordinated hydroxamic acid moiety in the Pt^II compounds synthesised, the corresponding pyridinecarboxylic acid (pycaH) complexes of general formula cis-[Pt^IICl₂(x-pycaH)₂] (where x = 3 or 4) and the Pt^II pyridine (py) complex, cis-[Pt^IICl₂(py)₂] were synthesised and served as reference standards. The NO-releasing properties of each of the Pt^II compounds, the pyhaH and the pycaH ligands were studied. The Pt^II pyridinehydroxamic acid derivatives were found to induce potent in vitro effects attributable to either NO-release from the hydroxamic acid moiety and/or stimulation of inducible nitric oxide synthase of endothelial cells.     

Hypoxanthine,xanthine and theobromine complexes with palladium(II) and platinum(IV) chlorides

Summary Complexes of the general types Pd(L)(LH)Cl (LH=hxH, xnH, or tbH) and Pt(L)(LH)Cl₃ (LH=hxH, or xnH) are formed by boiling under reflux 21 molar mixtures of hypoxanthine (hxH), xanthine (xnH) or theobromine (tbH) and PdCl₂ or PtCl₄ in ethanol-triethyl orthoformate. These complexes appear to be linear chain polymeric species, characterized by single monoanionic L^– ligands bridging between adjacent Pd²⁺ or Pt⁴⁺ ions. Inclusion of one terminal neutral LH and one terminal chloro-ligand completes the coordination sphere in the square-planar Pd²⁺ complexes, while the Pt⁴⁺ complexes aretrans-octahedral, involving three terminal chloro and one terminal LH ligand per platinum. The possible binding sites of the bidentate bridging L^– and the unidentate terminal LH are discussed.     

Synthesis, photophysical and electrophosphorescent properties of fluorene-based platinum(II) complexes

A series of platinum(II) complexes bearing tridentate cyclometalated C^N^N (C^N^N=6-phenyl-2,2'-bipyridine and π-extended R-C^N^N=3-[6'-(naphthalen-2'-yl)pyridin-2'-yl]isoquinoline) ligands with fluorene units have been synthesised and their photophysical properties have been studied. The fluorene units are incorporated into the cyclometalated ligands by a Suzuki coupling reaction. An increase in the π-conjugation of the cyclometalated ligands confers favourable photophysical properties compared to the 6-phenyl-2,2'-bipyridine analogues. The fluorene-based platinum(II) complexes display vibronic-structured emission bands with λ(max)=558-601 nm, and high emission quantum yields up to 0.76 in degassed dichloromethane. Their emissions are tentatively assigned to excited states with mixed (3)IL/(3)MLCT parentage (IL=intraligand, MLCT=metal-to-ligand charge transfer). The crystal structures of these platinum(II) complexes reveal extensive Pt(II)···π and/or π-π interactions. The fluorene-based platinum(II) complexes are soluble in organic solvents, have high thermal stability with decomposition temperature >350 °C, and can be thermally vacuum-sublimed or solution-processed as phosphorescent dopants for the fabrication of organic light-emitting diodes (OLEDs). A monochromic OLED with 3d as dopant (2 wt%) fabricated by vacuum deposition gave a current efficiency of 14.7 cd A(-1) and maximum brightness of 27000 cd m(-2). A high current efficiency (9.2 cd A(-1)) has been achieved in a solution-processed OLED using complex 3f (5 wt%) doped in a PVK (poly(9-vinylcarbazole)) host.     

Synthesis,spectroscopy and electrochemistry of mixed-ligand complexes of platinum(II) and palladium(II)

Mixed-ligand complexes [MX₂(MBPY)] (M = Pd^II or Pt^II; X = Cl^–, I^–, N^– ₃ or NO₂ ^–; MBPY = 4,4-dimethyl-2,2-bipyridine) have been prepared and characterised by elemental analyses, conductivity measurements, i.r., electronic absorption and ¹H-n.m.r. spectroscopic techniques. The cyclic voltammograms of these complexes suggest the involvement of the metal d orbital in the one-electron oxidation process and the * orbital of the MBPY in the one-electron reduction process. [Pt(MBPY)(N₃)₂] shows solution-state luminescence at room temperature.